FDA Inspection 1040175 — Damaris Rohsenow, Ph.D.
The FDA completed an inspection of Damaris Rohsenow, Ph.D. on Jan 11, 2018 in Providence, RI. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Providence, RI (United States)
Additional Details
Sponsor, Contract Research Organization